The MarketWatch News Department was not involved in the creation of this content. Booster Therapeutics is developing a novel therapeutic approach that aims to combat the accumulation of deviant ...

Booster Therapeutics is developing a novel therapeutic approach that aims to combat the accumulation of deviant proteins in cells, which are a major driver of Parkinson’s and other complex diseases ...

Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, announced today it has received a research grant ...